Bone Repairing Material

Bone Repairing Material Market Outlook

The global bone repairing material market is projected to reach approximately USD 20.5 billion by 2035, with a compound annual growth rate (CAGR) of around 7.5% during the forecast period from 2025 to 2035. This growth is primarily driven by the increasing incidence of orthopedic diseases and trauma cases, coupled with the rise in geriatric population that is more susceptible to fractures and bone-related ailments. Additionally, advancements in technology and innovative product development in the field of bone repair materials are playing a crucial role in market expansion. Increased healthcare expenditure and the demand for minimally invasive surgeries are further contributing to the market's growth. Furthermore, the expanding applications of bone repairing materials in dental and spinal surgeries are anticipated to enhance market penetration in the upcoming years.

Growth Factor of the Market

The growth of the bone repairing material market is influenced by a multitude of factors that collectively drive its expansion. One of the most significant factors is the rising prevalence of bone-related disorders, including osteoporosis and osteoarthritis, which necessitate effective repair materials for surgeries. Another critical growth factor is the technological advancements in biomaterials, such as the development of bioactive glasses and advanced ceramics that improve healing and integration with bone tissue. The increasing number of road accidents and sports injuries has also led to a surge in trauma cases, thus augmenting the demand for reliable bone repairing solutions. Furthermore, the growing acceptance of minimally invasive surgical techniques has prompted manufacturers to enhance their product offerings, resulting in a more robust market presence. Lastly, supportive government initiatives aimed at improving healthcare infrastructure and patient access to advanced medical treatments are expected to positively impact the market's growth trajectory.

Key Highlights of the Market

• The global market is expected to reach USD 20.5 billion by 2035.
• The CAGR is projected to be around 7.5% from 2025 to 2035.
• Technological advancements in biomaterials are enhancing market opportunities.
• Increased geriatric population is a significant factor driving market demand.
• The focus on minimally invasive surgical techniques is shaping market trends.

By Product Type

Bone Grafts:

Bone grafts are widely recognized in the bone repairing material market due to their natural ability to facilitate bone healing and regeneration. These materials can be derived from the patient’s own body (autografts), cadaveric sources (allografts), or even from animal sources (xenografts). The choice of graft depends on factors such as the site of injury and the patient’s overall health. Autografts are considered the gold standard, as they provide the best biological compatibility; however, their use is limited by the availability of donor sites. Allografts and xenografts serve as viable alternatives that offer significant advantages, including a reduced risk of donor site morbidity and a wider availability. Moreover, ongoing research is focusing on improving the efficacy of these grafts through innovative treatments, thus contributing to the growth of this segment.

Bone Allografts:

Bone allografts, which are sourced from donor bones, are becoming increasingly popular due to their efficacy in promoting healing and their versatility in various applications, particularly in orthopedic and dental surgeries. The use of allografts eliminates the need for harvesting bone from the patient, thereby minimizing surgical complications and recovery time. As these grafts are processed and sterilized to ensure safety, they maintain structural integrity while facilitating the integration of new bone growth. The segment is expected to witness significant growth due to rising awareness among healthcare professionals and patients about the benefits of allografts, as well as increasing acceptance in surgical procedures. Additionally, advancements in tissue engineering are set to enhance the performance of allografts, contributing to their growing market share.

Bone Xenografts:

Bone xenografts are materials derived from animal sources, primarily bovine bone, and they are gaining traction in the market due to their wide availability and cost-effectiveness. These grafts are processed to ensure that they are safe for human use, and they provide a scaffold for new bone to grow, which is particularly useful in dental and orthopedic procedures. The xenograft segment is anticipated to grow as more clinicians recognize their benefits and ease of use in situations where autografts and allografts may not be feasible. Furthermore, continuous innovations in processing techniques allow for improved biocompatibility and integration with human bone, making xenografts a valuable option in reconstructive surgeries.

Bone Substitutes:

Bone substitutes are synthetic materials designed to mimic the properties of natural bone. They have gained popularity due to their customizable nature and the ability to avoid complications associated with biological grafts. Composed of various materials such as ceramics, polymers, and composites, bone substitutes have the advantage of being readily available and free from the risks of disease transmission. Their applications span orthopedic, dental, and trauma surgeries, making them versatile in utilization across various medical fields. The segment is projected to grow significantly as advancements in materials science lead to the development of more effective and biocompatible options that improve patient outcomes.

Bone Growth Factors:

Bone growth factors, which are proteins that promote the growth and repair of bone tissue, are rapidly becoming a crucial part of the bone repairing materials landscape. They are often used in conjunction with grafts or substitutes to enhance the healing process and accelerate recovery times. Growth factors such as BMP-2 and BMP-7 are widely utilized in clinical settings, proving their efficacy in stimulating osteogenesis. As research progresses, new growth factors are being identified, and their application is expanding, particularly in complex cases where traditional materials may not provide sufficient healing. The increasing focus on personalized medicine and regenerative therapies is expected to propel the growth of this segment significantly in the coming years.

By Application

Orthopedic:

The orthopedic application segment is one of the largest contributors to the bone repairing material market, driven by the high incidence of musculoskeletal disorders and the increasing number of orthopedic surgeries performed globally. Procedures such as joint replacements, fracture repairs, and spinal surgeries require effective bone repairing materials to ensure successful outcomes. Innovations in surgical techniques, along with the demand for minimally invasive procedures, are fueling the adoption of advanced bone grafts and substitutes. Furthermore, as the global population ages, the prevalence of orthopedic conditions like osteoarthritis and osteoporosis rises, leading to an increased need for reliable bone repair solutions in this segment.

Dental:

Dental applications for bone repairing materials are witnessing significant growth due to rising awareness of oral health and increasing demand for dental implants. Bone grafts and substitutes play a vital role during dental surgeries, particularly in augmenting the jawbone for implant placements. Advances in dental technology and techniques have made it easier for practitioners to use bone repairing materials effectively, thus enhancing patient outcomes. Additionally, the growing aesthetic concerns among patients seeking cosmetic dental procedures is expected to drive the demand for bone repairing materials even further, as they are essential for successful implantations and restoration of oral functionality.

Trauma:

The trauma segment encompasses various incidents leading to bone injuries, such as accidents and falls, and is a significant market driver for bone repairing materials. The increasing incidence of trauma-related injuries, particularly in the aging population and active individuals, necessitates the use of effective materials to promote rapid healing. Bone grafts and substitutes are essential in managing fractures and facilitating the repair of damaged bone structures. The segment is anticipated to grow as healthcare facilities increasingly adopt innovative products and techniques for treating trauma cases, alongside government initiatives aimed at improving trauma care and rehabilitation services.

Spine:

The spine application segment is gaining momentum as spinal surgeries become more prevalent due to the rising occurrences of spinal disorders such as degenerative disc disease and spinal stenosis. Bone grafts, particularly those that incorporate growth factors, are essential in spinal fusion surgeries to enhance the fusion of vertebrae and improve spinal stability. As the demand for spinal procedures increases, driven by an aging population and higher incidences of back pain, the market for bone repairing materials in this segment is anticipated to expand steadily. Technological advancements, such as minimally invasive surgical techniques and enhanced imaging systems, are also propelling the growth of this segment, creating opportunities for new product development.

By Distribution Channel

Hospitals:

Hospitals represent a primary distribution channel for bone repairing materials, accounting for a significant share of the market. This trend is largely due to the increasing number of surgical procedures performed in hospitals, as they are equipped with advanced medical technologies and experienced surgeons. Furthermore, hospitals often have the resources to stock a wide variety of bone repairing materials, enabling them to cater to diverse patient needs. As the demand for orthopedic and dental surgeries continues to rise, hospitals are expected to remain a key channel for distributing bone repairing materials, fostering growth in this segment.

Specialty Clinics:

Specialty clinics, particularly those focused on orthopedics and dentistry, are emerging as an important distribution channel for bone repairing materials. These clinics often provide dedicated services and have specialized expertise in handling complex cases, making them a preferred choice for patients seeking targeted medical care. The advantage of specialty clinics lies in their ability to offer personalized treatment plans and tailored solutions, thus enhancing patient satisfaction. Additionally, as more patients seek out specialized care for bone-related issues, the role of specialty clinics in the distribution of bone repairing materials is likely to expand significantly.

Online Sales:

The online sales channel for bone repairing materials is gaining traction, primarily driven by the convenience and accessibility it offers to both healthcare providers and patients. The rise of e-commerce in the medical field allows for the quick procurement of various bone repairing materials, catering to the increasing demand for these products. Online platforms often provide detailed product information, enabling informed purchasing decisions based on specific medical needs. As technology continues to advance and more healthcare professionals embrace digital solutions, the online sales channel is expected to play a larger role in the bone repairing material market over the coming years.

By Ingredient Type

Ceramics:

Ceramics are widely used in the bone repairing materials market due to their biocompatibility and structural similarity to natural bone. They are typically employed in orthopedic and dental applications for their ability to promote osteoconduction, which is essential for bone healing. Types of ceramics such as hydroxyapatite and tricalcium phosphate are commonly used due to their favorable properties, including high porosity and bioactivity. The segment is expected to witness growth as more healthcare providers recognize the benefits of ceramics in enhancing patient outcomes and as advancements in ceramic technology continue to improve the performance of these materials.

Polymers:

Polymers are increasingly utilized in the bone repairing materials market for their versatility and ability to be engineered for specific applications. Biodegradable polymers, such as polylactic acid and polyglycolic acid, are particularly popular as they gradually dissolve in the body while promoting bone regeneration. These materials can be molded into different shapes, making them suitable for a variety of surgical procedures, including trauma and orthopedic surgeries. The growth of the polymer segment is fueled by ongoing research into new formulations and their applications in tissue engineering, which continue to expand the possibilities for effective bone repairing solutions.

Calcium Phosphate:

Calcium phosphate materials are critical in the bone repairing materials market due to their osteoconductive properties and similarity to human bone mineral. These materials are commonly used in various forms, including powders, granules, and coatings, making them adaptable for different surgical applications. The segment is projected to grow as research continues to demonstrate the efficacy of calcium phosphate in promoting bone healing and integration. Additionally, the increasing acceptance of calcium phosphate-based materials in surgical procedures is expected to enhance their market presence in the coming years, driven by growing clinical confidence in their use.

Collagen:

Collagen is a vital component in the bone repairing materials market due to its natural abundance and biocompatibility. As a key structural protein in the body, collagen supports cell attachment and proliferation, making it an ideal candidate for applications in bone repair. It is often used in conjunction with other materials, such as ceramics and growth factors, to improve healing outcomes. The segment is expected to grow as more manufacturers develop collagen-based products that cater to specific medical needs, and as the benefits of collagen in promoting bone regeneration become more widely recognized within clinical settings.

Growth Factors:

Growth factors play a crucial role in the bone repairing materials market as they are essential for promoting osteogenesis and accelerating the healing process. These proteins stimulate the differentiation of osteoblasts and enhance the body’s natural healing response. The segment is witnessing significant growth owing to the increasing focus on regenerative medicine and the development of new growth factor formulations that can be used in conjunction with grafts and substitutes. As clinicians seek to improve patient outcomes in complex surgeries, the use of growth factors is expected to rise, making this segment a focal point for manufacturers looking to innovate in the bone repairing materials market.

By Region

The bone repairing material market is witnessing diverse growth across various regions, with North America leading the market due to advanced healthcare infrastructure, high levels of medical expenditure, and a significant prevalence of orthopedic disorders. In North America, the market is expected to generate around USD 8.5 billion by 2035, reflecting a CAGR of approximately 7.0% from 2025 to 2035. The presence of major players and continuous technological advancements in biomaterials further bolster growth in this region. Europe is also a significant market for bone repairing materials, projected to reach around USD 6 billion by 2035, driven by the increasing geriatric population and rising awareness regarding the benefits of advanced surgical options.

In the Asia Pacific region, the market is anticipated to grow rapidly, reaching approximately USD 4.5 billion by 2035, with a CAGR of 8% during the forecast period. This growth is attributed to the rising incidence of road accidents, a burgeoning population, and increased healthcare access in emerging economies. Latin America and the Middle East & Africa are also expected to contribute to the market expansion, albeit at a slower pace, as healthcare infrastructure continues to improve. The increasing prevalence of trauma cases and orthopedic diseases in these regions will drive the demand for bone repairing materials, allowing for gradual yet steady market growth.

Opportunities

The bone repairing material market is ripe with opportunities driven by a plethora of factors on a global scale. One significant opportunity lies within the realm of research and development in tissue engineering and regenerative medicine, which is gaining traction in medical science. As scientists continue to explore new bioactive materials and advanced manufacturing techniques, there is potential for the introduction of novel products that enhance healing rates and integration with host tissues. The increasing focus on personalized medicine also opens avenues for tailored solutions that specifically cater to individual patient needs, further expanding the market. Additionally, as the demand for outpatient surgical procedures rises, there is an opportunity for manufacturers to develop innovative, easy-to-use products that facilitate quicker recovery times and enhance patient satisfaction.

Another promising opportunity exists in the growing awareness and emphasis on preventive healthcare measures and early intervention strategies. As healthcare providers prioritize proactive treatment plans for musculoskeletal health, there will be an increased demand for effective bone repairing materials. Moreover, emerging markets in Asia Pacific and Latin America present lucrative opportunities for manufacturers to expand their reach, especially as healthcare systems improve and access to advanced medical treatments increases. Collaborations with healthcare practitioners and institutions for clinical trials and product development can further accelerate growth in these regions. Overall, the landscape for the bone repairing material market is set to evolve, with numerous opportunities arising from technological advancements, demographic shifts, and changing healthcare priorities.

Threats

Despite the positive outlook for the bone repairing material market, several threats could potentially hinder its growth trajectory. One significant challenge arises from regulatory hurdles and the lengthy approval processes for new materials and products. Stringent regulations imposed by health authorities can delay the introduction of innovative solutions to the market, limiting the ability of manufacturers to address evolving consumer demands. Additionally, the market faces competition from alternative treatment options, such as biologics and advanced surgical techniques, which may reduce the reliance on traditional bone repairing materials. Furthermore, economic downturns and fluctuations in healthcare spending could impact market growth, as hospitals and clinics may opt for cost-effective solutions that prioritize budget constraints over advanced materials.

Another important threat is the potential for product recalls and safety concerns associated with bone repairing materials. If any materials are found to pose risks to patients or fail to meet safety standards, it could lead to a loss of consumer confidence and damage to the reputation of manufacturers. Moreover, the ever-evolving landscape of healthcare needs and patient preferences necessitates continuous innovation; failure to keep pace with advancements could result in a decline in market relevance. Lastly, supply chain disruptions, such as shortages of raw materials or logistics challenges, could impact the availability of bone repairing materials and hinder market growth.

Competitor Outlook

• Medtronic
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• DePuy Synthes (Johnson & Johnson)
• Smith & Nephew Plc
• NuVasive, Inc.
• Integra LifeSciences Corporation
• Osstem Implant Co., Ltd.
• RTI Surgical Holdings, Inc.
• Merck KGaA
• Bioventus LLC
• BoneSupport AB
• Heraeus Medical GmbH
• Collagen Solutions Plc
• AB Biomaterials Ltd.

The competitive landscape of the bone repairing material market is characterized by a diverse group of established players and emerging companies, each striving to maintain a competitive edge through innovation and strategic partnerships. Major companies in this market are continually investing in research and development to create advanced products that cater to the evolving needs of healthcare providers and patients. For instance, Medtronic and Stryker Corporation are known for their extensive portfolios that include a variety of bone grafts and substitutes, allowing them to address a range of orthopedic and dental applications. Additionally, companies like Zimmer Biomet and DePuy Synthes leverage their strong distribution networks and established relationships with healthcare professionals to expand their reach and improve market penetration.

Furthermore, there is an increasing trend of collaborations and mergers within the industry, as companies seek to enhance their product offerings and gain access to new technologies. For instance, Smith & Nephew has made strategic acquisitions to expand its portfolio of bone repairing materials, enabling it to compete more effectively in the market. Additionally, emerging players such as BoneSupport AB and Collagen Solutions Plc focus on niche segments, offering innovative solutions that cater to specific medical needs. This dynamic landscape fosters competition and encourages continuous innovation, resulting in a wide array of bone repairing materials that benefit patients and healthcare providers alike.

In terms of key information, companies such as Integra LifeSciences and RTI Surgical are recognized for their commitment to developing high-quality biomaterials that emphasize safety and efficacy. Integra LifeSciences has made significant strides in creating advanced collagen-based products and synthetic grafts, catering to the increasing demand for innovative solutions in bone repair. Meanwhile, RTI Surgical is known for its focus on allograft and xenograft solutions, contributing to its robust market presence. Additionally, Bioventus LLC and Heraeus Medical GmbH are prominent players in the growth factors segment, continuously advancing their product lines to include new formulations that promote faster healing and improved patient outcomes. Overall, the competitive landscape of the bone repairing material market is poised for further evolution as industry players navigate challenges and seize opportunities for growth.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Merck KGaA
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Bioventus LLC
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 BoneSupport AB
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 NuVasive, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Smith & Nephew Plc
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Stryker Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 AB Biomaterials Ltd.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Heraeus Medical GmbH
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Collagen Solutions Plc
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Osstem Implant Co., Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 RTI Surgical Holdings, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Zimmer Biomet Holdings, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Integra LifeSciences Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 DePuy Synthes (Johnson & Johnson)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Bone Repairing Material Market, By Application
    • 6.1.1 Orthopedic
    • 6.1.2 Dental
    • 6.1.3 Trauma
    • 6.1.4 Spine
  • 6.2 Bone Repairing Material Market, By Product Type
    • 6.2.1 Bone Grafts
    • 6.2.2 Bone Allografts
    • 6.2.3 Bone Xenografts
    • 6.2.4 Bone Substitutes
    • 6.2.5 Bone Growth Factors
  • 6.3 Bone Repairing Material Market, By Ingredient Type
    • 6.3.1 Ceramics
    • 6.3.2 Polymers
    • 6.3.3 Calcium Phosphate
    • 6.3.4 Collagen
    • 6.3.5 Growth Factors
  • 6.4 Bone Repairing Material Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Online Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Bone Repairing Material Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Bone Repairing Material market is categorized based on

By Product Type

• Bone Grafts
• Bone Allografts
• Bone Xenografts
• Bone Substitutes
• Bone Growth Factors

By Application

• Orthopedic
• Dental
• Trauma
• Spine

By Distribution Channel

• Hospitals
• Specialty Clinics
• Online Sales

By Ingredient Type

• Ceramics
• Polymers
• Calcium Phosphate
• Collagen
• Growth Factors

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• DePuy Synthes (Johnson & Johnson)
• Smith & Nephew Plc
• NuVasive, Inc.
• Integra LifeSciences Corporation
• Osstem Implant Co., Ltd.
• RTI Surgical Holdings, Inc.
• Merck KGaA
• Bioventus LLC
• BoneSupport AB
• Heraeus Medical GmbH
• Collagen Solutions Plc
• AB Biomaterials Ltd.